These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6848728)

  • 21. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
    Giebink GS; Foker JE; Kim Y; Schiffman G
    J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum opsonic activity after pneumococcal vaccination in splenectomized individuals as measured by a nitroblue tetrazolium (NBT) reduction micromethod.
    Urban T; Linné T; Jakobsson B; Jarstrand C
    J Clin Lab Immunol; 1986 Jan; 19(1):49-52. PubMed ID: 3701833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.
    Chudwin DS; Artrip SG; Korenblit A; Schiffman G; Rao S
    Infect Immun; 1985 Oct; 50(1):213-7. PubMed ID: 4044034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal polysaccharide immunization in infants and children.
    Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
    Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
    Landesman SH; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
    Kim KH; Seoh JY
    J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination.
    Wong WY; Overturf GD; Powars DR
    Clin Infect Dis; 1992 May; 14(5):1124-36. PubMed ID: 1600015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia.
    Buchanan GR; Schiffman G
    J Pediatr; 1980 Feb; 96(2):264-6. PubMed ID: 7351592
    [No Abstract]   [Full Text] [Related]  

  • 31. Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.
    Overturf GD; Rigau-Perez JG; Selzer J; Field RJ; Powars D; Pang EJ; Uy C; Honig G; Weiss J; Chan L; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):19-23. PubMed ID: 7091573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural and vaccine-related immunity to Streptococcus pneumoniae.
    Musher DM; Chapman AJ; Goree A; Jonsson S; Briles D; Baughn RE
    J Infect Dis; 1986 Aug; 154(2):245-56. PubMed ID: 3722865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.
    O'Brien KL; Swift AJ; Winkelstein JA; Santosham M; Stover B; Luddy R; Gootenberg JE; Nold JT; Eskenazi A; Snader SJ; Lederman HM
    Pediatrics; 2000 Nov; 106(5):965-72. PubMed ID: 11061761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactions to booster pneumococcal vaccination in patients with sickle cell disease.
    Rigau-Perez JG; Overturf GD; Chan LS; Weiss J; Powars D
    Pediatr Infect Dis; 1983; 2(3):199-202. PubMed ID: 6346278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults.
    Bardardottir E; Jonsson S; Jonsdottir I; Sigfusson A; Valdimarsson H
    J Infect Dis; 1990 Aug; 162(2):482-8. PubMed ID: 2373875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
    Nahm MH; Olander JV; Magyarlaki M
    J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-immunization pneumococcal antibody titers and IgG subclasses.
    Sorensen RU; Hidalgo H; Moore C; Leiva LE
    Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to pneumococcal vaccination in children younger than five years of age.
    Douglas RM; Paton JC; Duncan SJ; Hansman DJ
    J Infect Dis; 1983 Jul; 148(1):131-7. PubMed ID: 6886479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.